Guangdong Provincial People's Hospital
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 1946-01-01
- Employees
- -
- Market Cap
- -
A New Application of Amiloride in the Treatment of Patient With Chronic Kidney Disease In Reducing Urinary PROtein
Phase 4
Completed
- Conditions
- Chronic Kidney Diseases
- Interventions
- First Posted Date
- 2017-05-31
- Last Posted Date
- 2020-09-18
- Lead Sponsor
- Guangdong Provincial People's Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT03170336
- Locations
- 🇨🇳
Nephrology Dept,Guangdong General Hospital, Guangzhou, Guangdong, China
Mycophenolate Mofetil Plus Steroid in the Treatment Of Patients With Progressive Idiopathic Membranous Nephropathy
Phase 4
- Conditions
- Idiopathic Membranous Nephropathy
- Interventions
- Drug: Cyclosporins
- First Posted Date
- 2017-05-31
- Last Posted Date
- 2019-03-18
- Lead Sponsor
- Guangdong Provincial People's Hospital
- Target Recruit Count
- 128
- Registration Number
- NCT03170323
- Locations
- 🇨🇳
Guangdong General Hospital, Guangzhou, Guangdong, China
Acute Myocardial Infarction and Acute Cerebral Infarction (AMIAC) Registry and Follow-up
- Conditions
- Myocardial InfarctionChronic Kidney DiseasesCerebral InfarctionMortality
- First Posted Date
- 2017-05-25
- Last Posted Date
- 2017-05-25
- Lead Sponsor
- Guangdong Provincial People's Hospital
- Target Recruit Count
- 30000
- Registration Number
- NCT03166696
- Locations
- 🇨🇳
Guangdong General Hospital, Guangzhou, Guangdong, China
🇨🇳the First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China
🇨🇳Yue Bei People's Hospital, Shaoguan, Guangdong, China
Evaluating the Impact of Baduanjin Exercise Intervention on Quality of Life in Breast Cancer Survivors Receiving Aromatase Inhibitor Therapy
Not Applicable
Completed
- Conditions
- Breast Cancer Survivors Receiving Aromatase Inhibitor Therapy
- Interventions
- Other: Baduanjin exercise
- First Posted Date
- 2017-05-22
- Last Posted Date
- 2020-07-29
- Lead Sponsor
- Guangdong Provincial People's Hospital
- Target Recruit Count
- 86
- Registration Number
- NCT03162133
- Locations
- 🇨🇳
Guangdong General Hospital, Guangzhou, Guangdong, China
DCb (Docetaxel/Carboplatin) Versus EC-D (Epirubicin/Cyclophosphamide Followed by Docetaxe) as Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer
Phase 2
Completed
- Conditions
- Triple-Negative Breast Cancer
- Interventions
- First Posted Date
- 2017-05-16
- Last Posted Date
- 2022-09-01
- Lead Sponsor
- Guangdong Provincial People's Hospital
- Target Recruit Count
- 93
- Registration Number
- NCT03154749
- Locations
- 🇨🇳
Guangdong General Hospital, Guangzhou, Guangdong, China
TCH Versus EC-TH as Neoadjuvant Treatment for HER2-Positive Breast Cancer
Phase 2
Completed
- Conditions
- HER2-Positive Breast Cancer
- Interventions
- Drug: TCH (docetaxel/carboplatin/trastuzumab) versus EC-TH(epirubicin/cyclophosphamide followed by docetaxe plus trastuzumab)
- First Posted Date
- 2017-05-04
- Last Posted Date
- 2020-07-28
- Lead Sponsor
- Guangdong Provincial People's Hospital
- Target Recruit Count
- 140
- Registration Number
- NCT03140553
- Locations
- 🇨🇳
Guangdong General Hospital, Guangzhou, Guangdong, China
The Impact of Genotype on Pharmacokinetics and Antiplatelet Effects of Ticagrelor in Healthy Chinese
- First Posted Date
- 2017-03-27
- Last Posted Date
- 2017-03-27
- Lead Sponsor
- Guangdong Provincial People's Hospital
- Target Recruit Count
- 51
- Registration Number
- NCT03092076
Targeted Treatment With Intercalated Radiotherapy in EGFR-mutant IIIA/IIIB NSCLC
Phase 2
- Conditions
- Epidermal Growth Factor ReceptorNon-small Cell Lung Cancer
- Interventions
- First Posted Date
- 2017-03-09
- Last Posted Date
- 2017-03-09
- Lead Sponsor
- Guangdong Provincial People's Hospital
- Target Recruit Count
- 90
- Registration Number
- NCT03074864
- Locations
- 🇨🇳
Guangdong General Hospital, Guangzhou, Guangdong, China
Tacrolimus Combined With Entecavir on HBV Associated Glomerulonephritis(HBV-GN)
Phase 4
- Conditions
- Hepatitis B Virus Associated Nephrotic Syndrome
- Interventions
- First Posted Date
- 2017-02-23
- Last Posted Date
- 2017-02-24
- Lead Sponsor
- Guangdong Provincial People's Hospital
- Target Recruit Count
- 112
- Registration Number
- NCT03062813
- Locations
- 🇨🇳
Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China
Chidamide for Refractory/Relapsed Peripheral T Cell Lymphoma
- First Posted Date
- 2016-10-26
- Last Posted Date
- 2016-10-26
- Lead Sponsor
- Guangdong Provincial People's Hospital
- Target Recruit Count
- 12
- Registration Number
- NCT02944812
- Locations
- 🇨🇳
Guangdong general hospital, Guangzhou, Guangdong, China
© Copyright 2025. All Rights Reserved by MedPath